Adaptation and transformation biology of the mitochondrion to redox status is an emerging domain of physiology and pathophysiology. Mitochondrial adaptations occur in response to accidental changes in cellular energy demand or supply while mitochondrial transformations are a part of greater program of cell metamorphosis. The possible role of mitochondrial adaptations and transformations in pathogenesis remains unexplored, and it has become critical to decipher the stimuli and the underlying molecular pathways. Immediate activation of mitochondrial function was described during acute exercise, respiratory chain injury, Endoplasmic Reticulum stress, genotoxic stress, or environmental toxic insults. Delayed adaptations of mitochondrial form, composition, and functions were evidenced for persistent changes in redox status as observed in endurance training, in fibroblasts grown in presence of respiratory chain inhibitors or in absence of glucose, in the smooth muscle of patients with severe asthma, or in the skeletal muscle of patients with a mitochondrial disease. Besides, mitochondrial transformations were observed in the course of human cell differentiation, during immune response activation, or in cells undergoing carcinogenesis. Little is known on the signals and downstream pathways that govern mitochondrial adaptations and transformations. Few adaptative loops, including redox sensors, kinases, and transcription factors were deciphered, but their implication in physiology and pathology remains elusive. Mitoplasticity could play a protective role against aging, diabetes, cancer, or neurodegenerative diseases. Research on adaptation and transformation could allow the design of innovative therapies, notably in cancer. Antioxid. Redox Signal. 18, 808–849.
AlmeidaA, AlmeidaJ, BolanosJP, MoncadaS. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci U S A, 98:15294–15299. 2001.
4.
AlmeidaA, MoncadaS, BolanosJP. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol, 6:45–51. 2004.
5.
AmuthanG, BiswasG, AnanadatheerthavaradaHK, VijayasarathyC, ShephardHM, AvadhaniNG. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene, 21:7839–7849. 2002.
6.
AndrisF, DenanglaireS, BausE, RongvauxA, SteuveJ, FlavellRA, LeoO. Metabolic stress boosts humoral responses in vivo independently of inflammasome and inflammatory reaction. J Immunol, 186:2245–2253. 2011.
7.
AntelmanJ, ManandharG, YiYJ, LiR, WhitworthKM, SutovskyM, AgcaC, PratherRS, SutovskyP. Expression of mitochondrial transcription factor A (TFAM) during porcine gametogenesis and preimplantation embryo development. J Cell Physiol, 217:529–543. 2008.
8.
ArnouldT, VankoningslooS, RenardP, HoubionA, NinaneN, DemazyC, RemacleJ, RaesM. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. Embo J, 21:53–63. 2002.
9.
AtorinoL, SilvestriL, KoppenM, CassinaL, BallabioA, MarconiR, LangerT, CasariG. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol, 163:777–787. 2003.
10.
BaraccaA, ChiaradonnaF, SgarbiG, SolainiG, AlberghinaL, LenazG. Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. Biochim Biophys Acta, 1797:314–323. 2010.
11.
BeauI, MehrpourM, CodognoP. Autophagosomes and human diseases. Int J Biochem Cell Biol, 43:460–464. 2011.
12.
BecknerME, GobbelGT, AbounaderR, BurovicF, AgostinoNR, LaterraJ, PollackIF. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Lab Invest, 85:1457–1470. 2005.
13.
BellotG, Garcia-MedinaR, GounonP, ChicheJ, RouxD, PouyssegurJ, MazureNM. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol, 29:2570–2581. 2009.
BenardG, BellanceN, JoseC, RossignolR. Relationships Between Mitochondrial Dynamics and Bioenergetics. Mitochondrial Dynamics and Neurodegeneration. LuB. Dordrecht: Springer, 2011.
16.
BenardG, FaustinB, GalinierA, RocherC, BellanceN, SmolkovaK, CasteillaL, RossignolR, LetellierT. Functional dynamic compartmentalization of respiratory chain intermediate substrates: implications for the control of energy production and mitochondrial diseases. Int J Biochem Cell Biol, 40:1543–1554. 2008.
BenardG, NeutznerA, PengG, WangC, LivakF, YouleRJ, KarbowskiM. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation. EMBO J, 29:1458–1471. 2010.
19.
BenardG, RossignolR. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal, 10:1313–1342. 2008.
20.
This reference has been deleted.
21.
BenardG, TrianT, BellanceN, BergerP, LavieJ, EspilC, RocherC, Eimer-BouillotS, GoizetC, Nouette-GaulainK, LetellierT, LacombeD, RossignolR. Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction. Antioxid Redox Signal, 2012[Epub ahead of print]DOI:10.1089/ars.2011.4244.
22.
BenbrikE, ChariotP, BonavaudS, Ammi-SaidM, FrisdalE, ReyC, GherardiR, Barlovatz-MeimonG. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci, 149:19–25. 1997.
23.
BensaadK, CheungEC, VousdenKH. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J, 28:3015–3026. 2009.
24.
BensaadK, TsurutaA, SelakMA, VidalMN, NakanoK, BartronsR, GottliebE, VousdenKH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell, 126:107–120. 2006.
25.
BiswasG, AdebanjoOA, FreedmanBD, AnandatheerthavaradaHK, VijayasarathyC, ZaidiM, KotlikoffM, AvadhaniNG. Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J, 18:522–533. 1999.
26.
BonnetS, ArcherSL, Allalunis-TurnerJ, HaromyA, BeaulieuC, ThompsonR, LeeCT, LopaschukGD, PuttaguntaL, BonnetS, HarryG, HashimotoK, PorterCJ, AndradeMA, ThebaudB, MichelakisED. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell, 11:37–51. 2007.
27.
BourdineaudJP, BellanceN, BenardG, BrethesD, FujimuraM, GonzalezP, MarighettoA, Maury-BrachetR, MormedeC, PedronV, PhilippinJN, RossignolR, RosteneW, SawadaM, LaclauM. Feeding mice with diets containing mercury-contaminated fish flesh from French Guiana: a model for the mercurial intoxication of the Wayana Amerindians. Environ Health, 7:53. 2008.
28.
BourdineaudJP, FujimuraM, LaclauM, SawadaM, YasutakeA. Deleterious effects in mice of fish-associated methylmercury contained in a diet mimicking the Western populations' average fish consumption. Environ Int, 37:303–313. 2011.
29.
BouzierAK, VoisinP, GoodwinR, CanioniP, MerleM. Glucose and lactate metabolism in C6 glioma cells: evidence for the preferential utilization of lactate for cell oxidative metabolism. Dev Neurosci, 20:331–338. 1998.
30.
BravoR, VicencioJM, ParraV, TroncosoR, MunozJP, BuiM, QuirogaC, RodriguezAE, VerdejoHE, FerreiraJ, IglewskiM, ChiongM, SimmenT, ZorzanoA, HillJA, RothermelBA, SzabadkaiG, LavanderoS. Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J Cell Sci, 124:2143–2152. 2011.
BurnsDM, RichterJD. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev, 22:3449–3460. 2008.
33.
BuzzaiM, BauerDE, JonesRG, DeberardinisRJ, HatzivassiliouG, ElstromRL, ThompsonCB. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene, 24:4165–4173. 2005.
34.
CabezonE, MontgomeryMG, LeslieAG, WalkerJE. The structure of bovine F1-ATPase in complex with its regulatory protein IF1. Nat Struct Biol, 10:744–750. 2003.
35.
CambierS, BenardG, Mesmer-DudonsN, GonzalezP, RossignolR, BrethesD, BourdineaudJP. At environmental doses, dietary methylmercury inhibits mitochondrial energy metabolism in skeletal muscles of the zebra fish (Danio rerio)Int J Biochem Cell Biol, 41:791–799. 2009.
36.
CambierS, GonzalezP, Mesmer-DudonsN, BrethesD, FujimuraM, BourdineaudJP. Effects of dietary methylmercury on the zebrafish brain: histological, mitochondrial, and gene transcription analyses. Biometals, 25:165–180. 2012.
37.
CampanellaM, CasswellE, ChongS, FarahZ, WieckowskiMR, AbramovAY, TinkerA, DuchenMR. Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab, 8:13–25. 2008.
38.
CampisiJ, d'Adda di FagagnaF. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol, 8:729–740. 2007.
39.
CantoC, AuwerxJ. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol, 20:98–105. 2009.
40.
CantoC, Gerhart-HinesZ, FeigeJN, LagougeM, NoriegaL, MilneJC, ElliottPJ, PuigserverP, AuwerxJ. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 458:1056–1060. 2009.
41.
CarewJS, NawrockiST, XuRH, DunnerK, McConkeyDJ, WierdaWG, KeatingMJ, HuangP. Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia, 18:1934–1940. 2004.
42.
CereghettiGM, ScorranoL. The many shapes of mitochondrial death. Oncogene, 25:4717–4724. 2006.
43.
ChamiM, OulesB, SzabadkaiG, TacineR, RizzutoR, Paterlini-BrechotP. Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol Cell, 32:641–651. 2008.
44.
ChanceB, WilliamsGR. The respiratory chain and oxidative phophorylation. Adv Enzymol, 17:65–134. 1956.
45.
CharniS, de BettigniesG, RathoreMG, AguiloJI, van den ElsenPJ, HaouziD, HipskindRA, EnriquezJA, Sanchez-BeatoM, PardoJ, AnelA, VillalbaM. Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway. J Immunol, 185:3498–34503. 2010.
46.
ChenV, StaubRE, FongS, TagliaferriM, CohenI, ShtivelmanE. Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS. PLoS One, 7:e30300. 2012.
47.
CheungWD, HartGW. AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J Biol Chem, 283:13009–13020. 2008.
48.
ChevrollierA, LoiseauD, ChabiB, RenierG, DouayO, MalthieryY, StepienG. ANT2 isoform required for cancer cell glycolysis. J Bioenerg Biomembr, 37:307–316. 2005.
49.
ChevrollierA, LoiseauD, GautierF, MalthieryY, StepienG. ANT2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143B and HepG2 cancer cells. Mol Carcinog, 42:1–8. 2004.
50.
ChevrollierA, LoiseauD, ReynierP, StepienG. Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism. Biochim Biophys Acta, 1807:562–567. 2011.
51.
ColomboSL, MoncadaS. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J, 421:163–169. 2009.
52.
CuezvaJM, OstronoffLK, RicartJ, Lopez de HerediaM, Di LiegroCM, IzquierdoJM. Mitochondrial biogenesis in the liver during development and oncogenesis. J Bioenerg Biomembr, 29:365–377. 1997.
de GroofAJ, te LindertMM, van DommelenMM, WuM, WillemseM, SmiftAL, WinerM, OerlemansF, PlukH, FransenJA, WieringaB. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer, 8:54. 2009.
59.
DemariaM, GiorgiC, LebiedzinskaM, EspositoG, D'AngeliL, BartoliA, GoughDJ, TurksonJ, LevyDE, WatsonCJ, WieckowskiMR, ProveroP, PintonP, PoliV. A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction. Aging, 2:823–842. 2010.
60.
Di BellaD, LazzaroF, BruscoA, PlumariM, BattagliaG, PastoreA, FinardiA, CagnoliC, TempiaF, FrontaliM, VenezianoL, SaccoT, BodaE, BrussinoA, BonnF, CastellottiB, BarattaS, MariottiC, GelleraC, FracassoV, MagriS, LangerT, PlevaniP, Di DonatoS, Muzi-FalconiM, TaroniF. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet, 42:313–321. 2010.
61.
Diaz-RuizR, AveretN, AraizaD, PinsonB, Uribe-CarvajalS, DevinA, RigouletM. Mitochondrial oxidative phosphorylation is regulated by fructose 1,6-bisphosphate. A possible role in Crabtree effect induction?J Biol Chem, 283:26948–26955. 2008.
62.
DieterenCE, GielenSC, NijtmansLG, SmeitinkJA, SwartsHG, BrockR, WillemsPH, KoopmanWJ. Solute diffusion is hindered in the mitochondrial matrix. Proc Natl Acad Sci U S A, 108:8657–8662. 2011.
63.
DingWX, NiHM, LiM, LiaoY, ChenX, StolzDB, DornGW2nd, YinXM. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem, 285:27879–27890. 2010.
64.
DistelmaierF, VischHJ, SmeitinkJA, MayatepekE, KoopmanWJ, WillemsPH. The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency. J Mol Med, 87:515–522. 2009.
65.
Djavaheri-MergnyM, MaiuriMC, KroemerG. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene, 29:1717–9. 2010.
66.
DomenisR, ComelliM, BisettoE, MavelliI. Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. J Bioenerg Biomembr, 43:493–505. 2011.
67.
DonnelyM, SchefflerI. Energy metabolism in respiration deficient and wild type chinese hamster fibroblasts in culture. J Cell Physiol, 89:39–52. 1976.
68.
DuclosM, MartinC, MalgatM, MazatJP, ChaouloffF, MormedeP, LetellierT. Relationships between muscle mitochondrial metabolism and stress-induced corticosterone variations in rats. Pflugers Arch, 443:218–226. 2001.
69.
DudkinaNV, KudryashevM, StahlbergH, BoekemaEJ. Interaction of complexes I, III, and IV within the bovine respirasome by single particle cryoelectron tomography. Proc Natl Acad Sci U S A, 108:15196–15200. 2011.
70.
DykensJA, WillY. The significance of mitochondrial toxicity testing in drug development. Drug Discov Today, 12:777–785. 2007.
71.
EakinRT, MorganLO, GreggCT, MatwiyoffNA. Carbon-13 nuclear magnetic resonance spectroscopy of living cells and their metabolism of a specifically labeled 13C substrate. FEBS Lett, 28:259–264. 1972.
72.
EchtayKS, MurphyMP, SmithRA, TalbotDA, BrandMD. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem, 277:47129–47135. 2002.
73.
EfremovRG, BaradaranR, SazanovLA. The architecture of respiratory complex I. Nature, 465:441–445. 2010.
74.
EfremovRG, SazanovLA. Structure of the membrane domain of respiratory complex I. Nature, 476:414–420. 2011.
75.
EganDF, ShackelfordDB, MihaylovaMM, GelinoS, KohnzRA, MairW, VasquezDS, JoshiA, GwinnDM, TaylorR, AsaraJM, FitzpatrickJ, DillinA, ViolletB, KunduM, HansenM, ShawRJ. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science, 331:456–461. 2011.
76.
EhsesS, RaschkeI, MancusoG, BernacchiaA, GeimerS, TonderaD, MartinouJC, WestermannB, RugarliEI, LangerT. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol, 187:1023–1036. 2009.
77.
FaustinB, RossignolR, RocherC, BenardG, MalgatM, LetellierT. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem, 279:20411–20421. 2004.
78.
FeiP, WangW, KimSH, WangS, BurnsTF, SaxJK, BuzzaiM, DickerDT, McKennaWG, BernhardEJ, El-DeiryWS. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell, 6:597–609. 2004.
79.
FischerB, MullerB, FischP, KreutzW. An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy. J Immunother, 23:196–207. 2000.
80.
FogalV, RichardsonAD, KarmaliPP, SchefflerIE, SmithJW, RuoslahtiE. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol, 30:1303–1318. 2010.
81.
FolkersK, LangsjoenP, WillisR, RichardsonP, XiaLJ, YeCQ, TamagawaH. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci U S A, 87:8931–8934. 1990.
82.
FryerLG, FoufelleF, BarnesK, BaldwinSA, WoodsA, CarlingD. Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem J, 363:167–174. 2002.
83.
FunesJM, QuinteroM, HendersonS, MartinezD, QureshiU, WestwoodC, ClementsMO, BourbouliaD, PedleyRB, MoncadaS, BoshoffC. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci U S A, 104:6223–6228. 2007.
84.
GaoP, TchernyshyovI, ChangTC, LeeYS, KitaK, OchiT, ZellerKI, De MarzoAM, Van EykJE, MendellJT, DangCV. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature, 458:762–765. 2009.
85.
GasparreG, KurelacI, CapristoM, IommariniL, GhelliA, CeccarelliC, NicolettiG, NanniP, De GiovanniC, ScotlandiK, BettsCM, CarelliV, LolliniPL, RomeoG, RugoloM, PorcelliAM. A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function. Cancer Res, 71:6220–6229. 2011.
86.
GatenbyRA, GilliesRJ. Why do cancers have high aerobic glycolysis?Nat Rev Cancer, 4:891–899. 2004.
87.
GatenbyRA, GilliesRJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer, 8:56–61. 2008.
88.
GatzaE, WahlDR, OpipariAW, SundbergTB, ReddyP, LiuC, GlickGD, FerraraJL. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med, 3:67ra8. 2011.
89.
GeggME, CooperJM, ChauKY, RojoM, SchapiraAH, TaanmanJW. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet, 19:4861–4870. 2010.
90.
GeislerS, HolmstromKM, SkujatD, FieselFC, RothfussOC, KahlePJ, SpringerW. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol, 12:119–131. 2010.
91.
GellerichFN, GizatullinaZ, TrumbeckaiteS, KorzeniewskiB, GaynutdinovT, SeppetE, VielhaberS, HeinzeHJ, StriggowF. Cytosolic Ca2+ regulates the energisation of isolated brain mitochondria by formation of pyruvate through the malate-aspartate shuttle. Biochem, J443:747–755. 2012.
92.
GiorgioM, BerryA, BerniakovichI, PoletaevaI, TrineiM, StendardoM, HagopianK, RamseyJJ, CortopassiG, MigliaccioE, NotzliS, AmreinI, LippHP, CirulliF, PelicciPG. The p66Shc knocked out mice are short lived under natural condition. Aging Cell, 11:162–168. 2012.
93.
GnaigerE, KempRB. Anaerobic metabolism in aerobic mammalian cells: information from the ratio of calorimetric heat flux and respirometric oxygen flux. Biochim Biophys Acta, 1016:328–332. 1990.
94.
GomesLC, Di BenedettoG, ScorranoL. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol, 13:589–598. 2011.
95.
GosalvezM, MerchanJ. Letter: induction of rat mammary adenomas with respiratory inhibitory rotenone. Cancer Res, 33:3047–3050. 1973.
96.
GottliebE, TomlinsonIP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer, 5:857–866. 2005.
GrahamBH, WaymireKG, CottrellB, TrounceIA, MacGregorGR, WallaceDC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet, 16:226–234. 1997.
99.
GreerEL, OskouiPR, BankoMR, ManiarJM, GygiMP, GygiSP, BrunetA. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem, 282:30107–30119. 2007.
100.
GriguerCE, OlivaCR, GillespieGY. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines. J Neurooncol, 74:123–133. 2005.
101.
GstraunthalerG, SeppiT, PfallerW. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic?Cell Physiol Biochem, 9:150–172. 1999.
102.
HahnWC, CounterCM, LundbergAS, BeijersbergenRL, BrooksMW, WeinbergRA. Creation of human tumour cells with defined genetic elements. Nature, 400:464–468. 1999.
103.
HalliwellB. Oxidative stress in cell culture: an under-appreciated problem?FEBS Lett, 540:3–6. 2003.
104.
HamanakaRB, ChandelNS. Targeting glucose metabolism for cancer therapy. J Exp Med, 209:211–215. 2012.
105.
HanssonA, HanceN, DufourE, RantanenA, HultenbyK, ClaytonDA, WibomR, LarssonNG. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci U S A, 101:3136–3141. 2004.
106.
HaoW, ChangCP, TsaoCC, XuJ. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J Biol Chem, 285:12647–12654. 2010.
107.
HardieDG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol, 8:774–785. 2007.
108.
HardieDG, CarlingD, GamblinSJ. AMP-activated protein kinase: also regulated by ADP?Trends Biochem Sci, 36:470–477. 2011.
109.
HardieDG, ScottJW, PanDA, HudsonER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett, 546:113–120. 2003.
110.
HeerdtBG, HoustonMA, AugenlichtLH. The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. Cancer Res, 65:9861–9867. 2005.
111.
HeinrichR, RapoportT. Linear theory of enzymatic chain: its application for analysis of the crossover theorem and of the glycolisis of human erytrocyte. Acta Biol Med Germ, 31:479–494. 1973.
112.
HeinrichR, RapoportT. Mathematical anlysis of multienzyme systems. III. Steady-state and transient control. Biosystems, 7:130–136. 1975.
113.
HeinrichR, RapoportTA. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur J Biochem, 42:89–95. 1974.
114.
Herrero-MendezA, AlmeidaA, FernandezE, MaestreC, MoncadaS, BolanosJP. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nature Cell Biol, 11:747–752. 2009.
115.
HershkoA, CiechanoverA. The ubiquitin system. Ann Rev Biochem, 67:425–479. 1998.
116.
HervouetE, CizkovaA, DemontJ, VojtiskovaA, PecinaP, Franssen-van HalNL, KeijerJ, SimonnetH, IvanekR, KmochS, GodinotC, HoustekJ. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis, 29:1528–1537. 2008.
117.
Hickson-BickDL, JonesC, BujaLM. Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat cardiomyocyte protects against programmed cell death. J Mol Cell Cardiol, 44:411–418. 2008.
118.
HockMB, KralliA. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol, 71:177–203. 2009.
119.
HollisVS, Palacios-CallenderM, SpringettRJ, DelpyDT, MoncadaS. Monitoring cytochrome redox changes in the mitochondria of intact cells using multi-wavelength visible light spectroscopy. Biochim Biophys Acta, 1607:191–202. 2003.
120.
HoodDA, IrrcherI, LjubicicV, JosephAM. Coordination of metabolic plasticity in skeletal muscle. J Exp Biol, 209:2265–2275. 2006.
121.
HorvatS, BeyerC, SusanneA. Effect of hypoxia on the transcription pattern of subunit isoforms and the kinetics of cytochrome c oxidase in cortical astrocytes and cerebellar neurons. J Neurochem, 99:937–951. 2006.
122.
HosgoodHD3rd, LiuCS, RothmanN, WeinsteinSJ, BonnerMR, ShenM, LimU, VirtamoJ, ChengWL, AlbanesD, LanQ. Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis, 31:847–849. 2010.
123.
HunteC, ZickermannV, BrandtU. Functional modules and structural basis of conformational coupling in mitochondrial complex I. Science, 329:448–451. 2010.
124.
IndranIR, HandeMP, PervaizS. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res, 71:266–276. 2011.
JeffreeRL, WillsEJ, HarperC. An unusual myopathy: speckled muscle fibers due to enlarged mitochondria. Muscle Nerve, 36:118–122. 2007.
129.
JendrachM, MaiS, PohlS, VothM, Bereiter-HahnJ. Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion, 8:293–304. 2008.
130.
JoseC, BellanceN, ChatelainEH, BenardG, Nouette-GaulainK, RossignolR. Antiproliferative activity of levobupivacaine and aminoimidazole carboxamide ribonucleotide on human cancer cells of variable bioenergetic profile. Mitochondrion, 12:100–109. 2012.
131.
JoseC, BellanceN, RossignolR. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?Biochim Biophys Acta, 1807:552–561. 2011.
132.
KacserH. The control of enzyme systems in vivo: elasticity analysis of the steady state. Biochem SocTrans, 11:35–40. 1983.
133.
KacserH, BurnsJA. The control of flux. Symp Soc Exp Biol, 27:65–104. 1973.
134.
KacserH, PorteousJ. Control of metabolism: what do we have to measure?Trends Biochem Sci, 12:5–14. 1987.
135.
KandaY, WatanabeY. Thrombin-induced glucose transport via Src-p38 MAPK pathway in vascular smooth muscle cells. Br J Pharmacol, 146:60–67. 2005.
136.
KarbowskiM, NeutznerA, YouleRJ. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol, 178:71–84. 2007.
137.
KarumanP, GozaniO, OdzeRD, ZhouXC, ZhuH, ShawR, BrienTP, BozzutoCD, OoiD, CantleyLC, YuanJ. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell, 7:1307–1319. 2001.
138.
KimI, Rodriguez-EnriquezS, LemastersJJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys, 462:245–253. 2007.
139.
KimJH, KimHY, LeeYK, YoonYS, XuWG, YoonJK, ChoiSE, KoYG, KimMJ, LeeSJ, WangHJ, YoonG. Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiency. Autophagy, 7:1187–1198. 2011.
140.
KimJW, TchernyshyovI, SemenzaGL, DangCV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab, 3:177–185. 2006.
141.
KingA, SelakMA, GottliebE. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene, 25:4675–4682. 2006.
142.
KoopmanWJ, DistelmaierF, HinkMA, VerkaartS, WijersM, FransenJ, SmeitinkJA, WillemsPH. Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria. Am J Physiol Cell Physiol, 294:C1124–C1132. 2008.
143.
KoopmanWJ, HinkMA, VerkaartS, VischHJ, SmeitinkJA, WillemsPH. Partial complex I inhibition decreases mitochondrial motility and increases matrix protein diffusion as revealed by fluorescence correlation spectroscopy. Biochim Biophys Acta, 1767:940–947. 2007.
KoopmanWJ, VerkaartS, van Emst-de VriesSE, GrefteS, SmeitinkJA, WillemsPH. Simultaneous quantification of oxidative stress and cell spreading using 5-(and-6)-chloromethyl-2′,7′-dichlorofluorescein. Cytometry A, 69:1184–1192. 2006.
146.
KoopmanWJ, VerkaartS, VischHJ, van der WesthuizenFH, MurphyMP, van den HeuvelLW, SmeitinkJA, WillemsPH. Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. Am J Physiol Cell Physiol, 288:C1440–C1450. 2005.
147.
KoopmanWJ, VischHJ, SmeitinkJA, WillemsPH. Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytometry A, 69:1–12. 2006.
148.
KoopmanWJ, VischHJ, VerkaartS, van den HeuvelLW, SmeitinkJA, WillemsPH. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol Cell Physiol, 289:C881–C890. 2005.
149.
This reference has been deleted.
150.
KoopmanWJ, WillemsPH, OosterhofA, van KuppeveltTH, GielenSC. Amplitude modulation of nuclear Ca2+ signals in human skeletal myotubes: a possible role for nuclear Ca2+ buffering. Cell Calcium, 38:141–152. 2005.
KoukourakisMI, GiatromanolakiA, SivridisE, GatterKC, HarrisAL. Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia, 7:1–6. 2005.
153.
KumaA, HatanoM, MatsuiM, YamamotoA, NakayaH, YoshimoriT, OhsumiY, TokuhisaT, MizushimaN. The role of autophagy during the early neonatal starvation period. Nature, 432:1032–1036. 2004.
154.
KumarSH, RangarajanA. Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol, 83:8565–8574. 2009.
155.
LagougeM, ArgmannC, Gerhart-HinesZ, MezianeH, LerinC, DaussinF, MessadeqN, MilneJ, LambertP, ElliottP, GenyB, LaaksoM, PuigserverP, AuwerxJ. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 127:1109–1122. 2006.
156.
LanQ, LimU, LiuCS, WeinsteinSJ, ChanockS, BonnerMR, VirtamoJ, AlbanesD, RothmanN. A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma. Blood, 112:4247–4249. 2008.
157.
LebiedzinskaM, Karkucinska-WieckowskaA, GiorgiC, KarczmarewiczE, PronickaE, PintonP, DuszynskiJ, PronickiM, WieckowskiMR. Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders. Biochim Biophys Acta, 1797:952–960. 2010.
158.
LeonhardK, HerrmannJM, StuartRA, MannhauptG, NeupertW, LangerT. AAA proteases with catalytic sites on opposite membrane surfaces comprise a proteolytic system for the ATP-dependent degradation of inner membrane proteins in mitochondria. EMBO J, 15:4218–4229. 1996.
159.
LereboursA, Adam-GuillerminC, BrethesD, FrelonS, FlorianiM, CamilleriV, Garnier-LaplaceJ, BourdineaudJP. Mitochondrial energetic metabolism perturbations in skeletal muscles and brain of zebrafish (Danio rerio) exposed to low concentrations of waterborne uranium. Aquat Toxicol, 100:66–74. 2010.
160.
LetellierT, HeinrichR, MalgatM, MazatJP. The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J, 302,Pt 1:171–174. 1994.
161.
LeverveXM. Mitochondrial function and substrate availability. Crit Care Med, 35:S454–S460. 2007.
162.
LeverveXM, FontaineE. Role of substrates in the regulation of mitochondrial function in situ. IUBMB Life, 52:221–229. 2001.
163.
LiaoLM, BaccarelliA, ShuXO, GaoYT, JiBT, YangG, LiHL, HoxhaM, DioniL, RothmanN, ZhengW, ChowWH. Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev, 20:1944–1949. 2011.
LiuW, Acin-PerezR, GeghmanKD, ManfrediG, LuB, LiC. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc Natl Acad Sci U S A, 108:12920–12924. 2011.
166.
LoiseauD, ChevrollierA, DouayO, VavasseurF, RenierG, ReynierP, MalthieryY, StepienG. Oxygen consumption and expression of the adenine nucleotide translocator in cells lacking mitochondrial DNA. Exp Cell Res, 278:12–18. 2002.
167.
LombesA, MendellJR, NakaseH, BarohnRJ, BonillaE, ZevianiM, YatesAJ, OmerzaJ, GalesTL, NakaharaKet al.Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol, 26:20–33. 1989.
168.
Lopez-RiosF, Sanchez-AragoM, Garcia-GarciaE, OrtegaAD, BerrenderoJR, Pozo-RodriguezF, Lopez-EncuentraA, BallestinC, CuezvaJM. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res, 67:9013–9017. 2007.
LuH, ForbesRA, VermaA. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem, 277:23111–23115. 2002.
171.
LumJJ, BauerDE, KongM, HarrisMH, LiC, LindstenT, ThompsonCB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 120:237–248. 2005.
172.
LuminiJA, MagalhaesJ, OliveiraPJ, AscensaoA. Beneficial effects of exercise on muscle mitochondrial function in diabetes mellitus. Sports Med, 38:735–750. 2008.
173.
Lumini-OliveiraJ, MagalhaesJ, PereiraCV, AleixoI, OliveiraPJ, AscensaoA. Endurance training improves gastrocnemius mitochondrial function despite increased susceptibility to permeability transition. Mitochondrion, 9:454–462. 2009.
174.
LynchSM, WeinsteinSJ, VirtamoJ, LanQ, LiuCS, ChengWL, RothmanN, AlbanesD, Stolzenberg-SolomonRZ. Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila), 4:1912–1919. 2011.
175.
MaiuriMC, CriolloA, KroemerG. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J, 29:515–516. 2010.
176.
Marin-HernandezA, Gallardo-PerezJC, RalphSJ, Rodriguez-EnriquezS, Moreno-SanchezR. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem, 9:1084–1101. 2009.
177.
MartinsI, GalluzziL, KroemerG. Hormesis, cell death and aging. Aging, 3:821–828. 2011.
178.
MathupalaSP, RempelA, PedersenPL. Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr, 29:339–343. 1997.
MazatJP, RossignolR, MalgatM, RocherC, FaustinB, LetellierT. What do mitochondrial diseases teach us about normal mitochondrial functions that we already knew: threshold expression of mitochondrial defects. Biochim Biophys Acta, 1504:20–30. 2001.
181.
MazurekS. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol, 43:969–980. 2010.
182.
MeijerAJ, CodognoP. Autophagy: regulation by energy sensing. Curr Biol CB, 21:R227–R229. 2011.
183.
MercyL, PauwA, PayenL, TejerinaS, HoubionA, DemazyC, RaesM, RenardP, ArnouldT. Mitochondrial biogenesis in mtDNA-depleted cells involves a Ca2+-dependent pathway and a reduced mitochondrial protein import. Febs J, 272:5031–5055. 2005.
184.
MichelS, WanetA, De PauwA, RommelaereG, ArnouldT, RenardP. Crosstalk between mitochondrial (dys)function and mitochondrial abundance. J Cell Physiol, 227:2297–2310. 2011.
185.
MitchellP. Coupling of phosphorylation to electron and hydrogen transfert by a chemi-osmotic type of mechanism. Nature, 191:144–148. 1961.
NakaiT, YasuharaT, FujikiY, OhashiA. Multiple genes, including a member of the AAA family, are essential for degradation of unassembled subunit 2 of cytochrome c oxidase in yeast mitochondria. Mol Cell Biol, 15:4441–4452. 1995.
190.
NarendraD, TanakaA, SuenDF, YouleRJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol, 183:795–803. 2008.
191.
NarendraD, TanakaA, SuenDF, YouleRJ. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy, 5:706–708. 2009.
192.
NiemannS, MullerU. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet, 26:268–270. 2000.
193.
NishidaY, ArakawaS, FujitaniK, YamaguchiH, MizutaT, KanasekiT, KomatsuM, OtsuK, TsujimotoY, ShimizuS. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature, 461:654–658. 2009.
194.
NolandRC, HicknerRC, Jimenez-LinanM, Vidal-PuigA, ZhengD, DohmGL, CortrightRN. Acute endurance exercise increases skeletal muscle uncoupling protein-3 gene expression in untrained but not trained humans. Metabolism, 52:152–158. 2003.
195.
Nouette-GaulainK, JoseC, CapdevilaX, RossignolR. From analgesia to myopathy: when local anesthetics impair the mitochondrion. Int J Biochem Cell Biol, 43:14–19. 2011.
196.
NovakI, KirkinV, McEwanDG, ZhangJ, WildP, RozenknopA, RogovV, LohrF, PopovicD, OcchipintiA, ReichertAS, TerzicJ, DotschV, NeyPA, DikicI. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep, 11:45–51. 2010.
197.
OakhillJS, SteelR, ChenZP, ScottJW, LingN, TamS, KempBE. AMPK is a direct adenylate charge-regulated protein kinase. Science, 332:1433–1435. 2011.
198.
OhnamiS, MatsumotoN, NakanoM, AokiK, NagasakiK, SugimuraT, TeradaM, YoshidaT. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. Cancer Res, 59:5565–5571. 1999.
199.
OkatsuK, SaishoK, ShimanukiM, NakadaK, ShitaraH, SouYS, KimuraM, SatoS, HattoriN, KomatsuM, TanakaK, MatsudaN. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells, 15:887–900. 2010.
200.
OkorokovAL, MilnerJ. An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes. Mol Cell Biol, 19:7501–7510. 1999.
201.
OkunieffP, VaupelP, SedlacekR, NeuringerLJ. Evaluation of tumor energy metabolism and microvascular blood flow after glucose or mannitol administration using 31P nuclear magnetic resonance spectroscopy and laser Doppler flowmetry. Int J Radiat Oncol Biol Phys, 16:1493–1500. 1989.
202.
PapandreouI, CairnsRA, FontanaL, LimAL, DenkoNC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab, 3:187–197. 2006.
203.
ParkJY, WangPY, MatsumotoT, SungHJ, MaW, ChoiJW, AndersonSA, LearySC, BalabanRS, KangJG, HwangPM. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res, 105:705–71211 p following 7122009.
PedersenPL, GreenawaltJW, ChanTL, MorrisHP. A comparison of some ultrastructural and biochemical properties of mitochondria from Morris hepatomas 9618A, 7800, and 3924A. Cancer Res, 30:2620–2626. 1970.
208.
PelicanoH, XuRH, DuM, FengL, SasakiR, CarewJS, HuY, RamdasL, HuL, KeatingMJ, ZhangW, PlunkettW, HuangP. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol, 175:913–923. 2006.
PeresS, ValleeF, Beurton-AimarM, MazatJP. ACoM: a classification method for elementary flux modes based on motif finding. Bio Syst, 103:410–419. 2011.
211.
PerryCG, LallyJ, HollowayGP, HeigenhauserGJ, BonenA, SprietLL. Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol, 588:4795–4810. 2010.
212.
PiccoliC, ScrimaR, BoffoliD, CapitanioN. Control by cytochrome c oxidase of the cellular oxidative phosphorylation system depends on the mitochondrial energy state. Biochem J, 396:573–583. 2006.
213.
PichS, BachD, BrionesP, LiesaM, CampsM, TestarX, PalacinM, ZorzanoA. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet, 14:1405–1415. 2005.
214.
PintonP, RimessiA, MarchiS, OrsiniF, MigliaccioE, GiorgioM, ContursiC, MinucciS, MantovaniF, WieckowskiMR, Del SalG, PelicciPG, RizzutoR. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science, 315:659–663. 2007.
215.
Plecita-HlavataL, LessardM, SantorovaJ, BewersdorfJ, JezekP. Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochondrial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy. Biochim Biophys Acta, 1777:834–846. 2008.
216.
PollardPJ, BriereJJ, AlamNA, BarwellJ, BarclayE, WorthamNC, HuntT, MitchellM, OlpinS, MoatSJ, HargreavesIP, HealesSJ, ChungYL, GriffithsJR, DalgleishA, McGrathJA, GleesonMJ, HodgsonSV, PoulsomR, RustinP, TomlinsonIP. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet, 14:2231–2239. 2005.
217.
PriaultM, SalinB, SchaefferJ, ValletteFM, di RagoJP, MartinouJC. Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ, 12:1613–1621. 2005.
RadoshevichL, MurrowL, ChenN, FernandezE, RoyS, FungC, DebnathJ. ATG12 conjugation to ATG3 regulates mitochondrial homeostasy and cell death. Cell, 142:590–600. 2010.
220.
RakovicA, GrunewaldA, KottwitzJ, BruggemannN, PramstallerPP, LohmannK, KleinC. Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS One, 6:e16746. 2011.
221.
RasolaA, SciacovelliM, ChiaraF, PanticB, BrusilowWS, BernardiP. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci U S A, 107:726–731. 2010.
222.
ReitzerL, WiceB, KennelD. Evidence that glutamine, not sugar, is the major energy source for cultured Hela cells. JBC, 254:2669–2676. 1979.
223.
This reference has been deleted.
224.
RezvaniHR, DedieuS, NorthS, BellocF, RossignolR, LetellierT, de VerneuilH, TaiebA, MazurierF. Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J Biol Chem, 282:16413–16422. 2007.
225.
RezvaniHR, KimAL, RossignolR, AliN, DalyM, MahfoufW, BellanceN, TaiebA, de VerneuilH, MazurierF, BickersDR. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest, 121:195–211. 2011.
226.
RezvaniHR, RossignolR, AliN, BenardG, TangX, YangHS, JouaryT, de VerneuilH, TaiebA, KimAL, MazurierF. XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochim Biophys Acta, 1807:609–619. 2011.
227.
Rodriguez-EnriquezS, JuarezO, Rodriguez-ZavalaJS, Moreno-SanchezR. Multisite control of the Crabtree effect in ascites hepatoma cells. Eur J Biochem, 268:2512–2519. 2001.
RossignolR, GilkersonR, AggelerR, YamagataK, RemingtonSJ, CapaldiRA. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res, 64:985–993. 2004.
231.
RugarliEI, LangerT. Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia. Trends Mol Med, 12:262–269. 2006.
232.
SalwayJG. Metabolism at a Glance. Blacwell Publishing: London, 2010.
233.
SasabeE, YangZ, OhnoS, YamamotoT. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells. Free Radic Biol Med, 48:1321–1329. 2010.
234.
SchaferJR, FellDA, RothmanD, ShulmanRG. Protein phosphorylation can regulate metabolite concentrations rather than control flux: the example of glycogen synthase. Proc Natl Acad Sci U S A, 101:1485–1490. 2004.
235.
Scherz-ShouvalR, ShvetsE, ElazarZ. Oxidation as a post-translational modification that regulates autophagy. Autophagy, 3:371–373. 2007.
236.
Scherz-ShouvalR, ShvetsE, FassE, ShorerH, GilL, ElazarZ. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J, 26:1749–1760. 2007.
237.
SchrauwenP, HesselinkM. Uncoupling protein 3 and physical activity: the role of uncoupling protein 3 in energy metabolism revisited. Proc Nutr Soc, 62:635–643. 2003.
238.
SchwimmerC, Lefebvre-LegendreL, RakM, DevinA, SlonimskiPP, di RagoJP, RigouletM. Increasing mitochondrial substrate-level phosphorylation can rescue respiratory growth of an ATP synthase-deficient yeast. J Biol Chem, 280:30751–30759. 2005.
239.
SemenzaGL. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J, 405:1–9. 2007.
240.
SgarbiG, CasalenaGA, BaraccaA, LenazG, DiMauroS, SolainiG. Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy. Arch Neurol, 66:951–957. 2009.
ShiDY, XieFZ, ZhaiC, SternJS, LiuY, LiuSL. The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol Cancer, 8:32. 2009.
245.
ShoubridgeEA, KarpatiG, HastingsKE. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell, 62:43–49. 1990.
246.
SmolkovaK, BellanceN, ScandurraF, GenotE, GnaigerE, Plecita-HlavataL, JezekP, RossignolR. Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J Bioenerg Biomembr, 42:55–67. 2010.
247.
This reference has been deleted.
248.
This reference has been deleted.
249.
SmolkovaK, Plecita-HlavataL, BellanceN, BenardG, RossignolR, JezekP. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol, 43:950–968. 2011.
250.
SorianoFX, LiesaM, BachD, ChanDC, PalacinM, ZorzanoA. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes, 55:1783–1791. 2006.
251.
SpiegelmanBM. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp, 287:60–63discussion 63–692007.
252.
SteglichG, NeupertW, LangerT. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol Cell Biol, 19:3435–3442. 1999.
253.
SterkyFH, LeeS, WibomR, OlsonL, LarssonNG. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A, 108:12937–12942. 2011.
254.
SuskiJM, LebiedzinskaM, BonoraM, PintonP, DuszynskiJ, WieckowskiMR. Relation between mitochondrial membrane potential and ROS formation. Methods Mol Biol, 810:183–205. 2012.
255.
SutovskyP, Van LeyenK, McCauleyT, DayBN, SutovskyM. Degradation of paternal mitochondria after fertilization: implications for heteroplasmy, assisted reproductive technologies and mtDNA inheritance. Reprod Biomed Online, 8:24–33. 2004.
256.
SuzukiT, MurakamiT, IinoR, SuzukiJ, OnoS, ShirakiharaY, YoshidaM. F0F1-ATPase/synthase is geared to the synthesis mode by conformational rearrangement of epsilon subunit in response to proton motive force and ADP/ATP balance. J Biol Chem, 278:46840–46846. 2003.
257.
SweeneyG, SomwarR, RamlalT, VolchukA, UeyamaA, KlipA. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem, 274:10071–10078. 1999.
258.
TalbotDA, LambertAJ, BrandMD. Production of endogenous matrix superoxide from mitochondrial complex I leads to activation of uncoupling protein 3. FEBS Lett, 556:111–115. 2004.
259.
Tanc. The Cell Biology of the Mitochondrial Protein IF1. University College London, 2011.
260.
TanakaA, ClelandMM, XuS, NarendraDP, SuenDF, KarbowskiM, YouleRJ. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol, 191:1367–1380. 2010.
261.
TangF, WangB, LiN, WuY, JiaJ, SuoT, ChenQ, LiuYJ, TangJ. RNF185, a Novel MITOCHONDRIAL Ubiquitin E3 Ligase, Regulates Autophagy through Interaction with BNIP1. PLoS One, 6:e24367. 2011.
TeckmanJH, AnJK, BlomenkampK, SchmidtB, PerlmutterD. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol, 286:G851–G862. 2004.
TwigG, ElorzaA, MolinaAJ, MohamedH, WikstromJD, WalzerG, StilesL, HaighSE, KatzS, LasG, AlroyJ, WuM, PyBF, YuanJ, DeeneyJT, CorkeyBE, ShirihaiOS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J, 27:433–446. 2008.
268.
This reference has been deleted.
269.
UmSH, D'AlessioD, ThomasG. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab, 3:393–402. 2006.
270.
van BeekJH, HauschildAC, HettlingH, BinslTW. Robust modelling, measurement and analysis of human and animal metabolic systems. Philos Transact A Math Phys Eng Sci, 367:1971–1992. 2009.
271.
VanhaesebroeckB, AlessiDR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J, 346,Pt 3:561–576. 2000.
272.
VankoningslooS, De PauwA, HoubionA, TejerinaS, DemazyC, de LonguevilleF, BertholetV, RenardP, RemacleJ, HolvoetP, RaesM, ArnouldT. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J Cell Sci, 119:1266–1282. 2006.
273.
This reference has been deleted.
274.
VaughnAE, DeshmukhM. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol, 10:1477–1483. 2008.
275.
VaupelP. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist, 13,Suppl 3:21–26. 2008.
276.
VaupelP, HockelM, MayerA. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal, 9:1221–1235. 2007.
277.
VaupelP, MayerA. Effects of anemia and hypoxia on tumor biology. Anemia in Cancer. European Scholl of Oncology Scientific Updates. BokemeyerC, LudwigH. New York: Elsevier Science, 2005; 47–54.
278.
VaupelP, MayerA, BriestS, HockelM. Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res, 63:7634–7637. 2003.
279.
VerkaartS, KoopmanWJ, CheekJ, van Emst-de VriesSE, van den HeuvelLW, SmeitinkJA, WillemsPH. Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. Biochim Biophys Acta, 1772:1041–1051. 2007.
280.
VerkaartS, KoopmanWJ, van Emst-de VriesSE, NijtmansLG, van den HeuvelLW, SmeitinkJA, WillemsPH. Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim Biophys Acta, 1772:373–381. 2007.
281.
VlashiE, LagadecC, VergnesL, MatsutaniT, MasuiK, PoulouM, PopescuR, Della DonnaL, EversP, DekmezianC, ReueK, ChristofkH, MischelPS, PajonkF. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A, 108:16062–16067. 2011.
282.
VotyakovaTV, ReynoldsIJ. DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria. J Neurochem, 79:266–277. 2001.
283.
WallaceD. Mitochondrial diseases in man and mouse. Science, 283:1482–1488. 1999.
WeinbergF, HamanakaR, WheatonWW, WeinbergS, JosephJ, LopezM, KalyanaramanB, MutluGM, BudingerGR, ChandelNS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A, 107:8788–8793. 2010.
WigfieldSM, WinterSC, GiatromanolakiA, TaylorJ, KoukourakisML, HarrisAL. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer. Br J Cancer, 98:1975–1984. 2008.
288.
WiseDR, DeBerardinisRJ, MancusoA, SayedN, ZhangXY, PfeifferHK, NissimI, DaikhinE, YudkoffM, McMahonSB, ThompsonCB. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A, 105:18782–18787. 2008.
289.
WredenbergA, WibomR, WilhelmssonH, GraffC, WienerHH, BurdenSJ, OldforsA, WesterbladH, LarssonNG. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci U S A, 99:15066–15071. 2002.
290.
WuZ, HuangX, FengY, HandschinC, GullicksenPS, BareO, LabowM, SpiegelmanB, StevensonSC. Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc Natl Acad Sci U S A, 103:14379–14384. 2006.
291.
XiaoB, SandersMJ, UnderwoodE, HeathR, MayerFV, CarmenaD, JingC, WalkerPA, EcclestonJF, HaireLF, SaiuP, HowellSA, AaslandR, MartinSR, CarlingD, GamblinSJ. Structure of mammalian AMPK and its regulation by ADP. Nature, 472:230–233. 2011.
292.
XuS, PengG, WangY, FangS, KarbowskiM. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol Biol Cell, 22:291–300. 2011.
293.
YanH, ParsonsDW, JinG, McLendonR, RasheedBA, YuanW, KosI, Batinic-HaberleI, JonesS, RigginsGJ, FriedmanH, FriedmanA, ReardonD, HerndonJ, KinzlerKW, VelculescuVE, VogelsteinB, BignerDD. IDH1 and IDH2 mutations in gliomas. N Engl J Med, 360:765–773. 2009.
294.
YangC, SudderthJ, DangT, BachooRM, McDonaldJG, DeBerardinisRJ. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res, 69:7986–7993. 2009.
295.
YuT, RobothamJL, YoonY. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A, 103:2653–2658. 2006.
296.
YunJ, RagoC, CheongI, PagliariniR, AngenendtP, RajagopalanH, SchmidtK, WillsonJK, MarkowitzS, ZhouS, DiazLAJr., VelculescuVE, LengauerC, KinzlerKW, VogelsteinB, PapadopoulosN. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science, 325:1555–1559. 2009.
297.
ZhangBB, ZhouG, LiC. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab, 9:407–416. 2009.
298.
ZhangC, LinM, WuR, WangX, YangB, LevineAJ, HuW, FengZ. Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A, 108:16259–16264. 2011.
299.
ZhouS, KachhapS, SinghKK. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis, 18:287–292. 2003.